Cyclophosphamide and Intestinal infarction - a phase IV clinical study of FDA data

Summary:

Intestinal infarction is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Docetaxel, and have Breast cancer.

The phase IV clinical study analyzes which people have Intestinal infarction when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Intestinal infarction?

Intestinal infarction (intestinal tissue death) is found to be associated with 178 drugs and 405 conditions by eHealthMe. Check the latest studies of Intestinal infarction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 19 people (0.01%) have Intestinal infarction.

Could Cyclophosphamide cause Intestinal infarction?

Among these 19 people:

How long have people been on Cyclophosphamide when they have Intestinal infarction? *

What is the gender of people who have Intestinal infarction when taking Cyclophosphamide? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Intestinal infarction when taking Cyclophosphamide? *

What are other drugs people take besides Cyclophosphamide? *

Taxotere: 4 people, 21.05%
Docetaxel: 4 people, 21.05%
Doxorubicin Hydrochloride: 3 people, 15.79%
Ranitidine: 3 people, 15.79%
Prednisolone: 3 people, 15.79%
Ondansetron: 3 people, 15.79%
Neulasta: 3 people, 15.79%
Dexamethasone: 3 people, 15.79%
Decadron: 3 people, 15.79%
Cisplatin: 2 people, 10.53%

What are other side effects people have besides Intestinal infarction? *

Thrombocytopenia (decrease of platelets in blood): 5 people, 26.32%
White Blood Cell Count Decreased: 4 people, 21.05%
Acute Kidney Failure: 4 people, 21.05%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 21.05%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 4 people, 21.05%
Respiratory Rate Increased (excess breathing rate/min): 3 people, 15.79%
Anoxic Encephalopathy (brain damage due to lack of oxygen): 3 people, 15.79%
Arrhythmias (irregular heartbeat): 3 people, 15.79%
Blood Creatinine Increased: 3 people, 15.79%
Blood Pressure Diastolic Decreased: 3 people, 15.79%

What are the existing conditions these people have? *

Breast Cancer: 4 people, 21.05%
Post Transplant Lymphoproliferative Disorder: 2 people, 10.53%
Vasculitis (inflammation of a blood vessel or blood vessels): 1 person, 5.26%
Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 1 person, 5.26%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 5.26%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.26%
Lymphoma (cancer that begins in immune system cells): 1 person, 5.26%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 5.26%
Breast Cancer Stage Iv: 1 person, 5.26%
Amyloidosis (a tumour within which amyloid is produced): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and have Intestinal infarction?

- Check whether Intestinal infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:

Cyclophosphamide (185,240 reports)

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal infarction:

Intestinal infarction (178 drugs)

Browse all the conditions that are associated with Intestinal infarction:

Intestinal infarction (405 conditions)

Related publications that referenced our studies

Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.